Market closed

DexCom/DXCM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About DexCom

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Ticker

DXCM
Trading on

Industry

Health Care Equipment & Supplies

Employees

9,550

DexCom Metrics

BasicAdvanced
$28B
Market cap
42.83
P/E ratio
$1.62
EPS
1.16
Beta
-
Dividend rate
$28B
1.16
$142.00
$62.34
4.1M
2.815
2.392
105.685
106.573
35.49%
6.25%
29.41%
42.826
6.861
11.39
12.08
40.564
23.05%
86.93%
21.94%
5.45%

What the Analysts think about DexCom

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for DexCom stock.

DexCom Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

DexCom Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy DXCM

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for DexCom stock?

DexCom (DXCM) has a market cap of $28B as of October 12, 2024.

What is the P/E ratio for DexCom stock?

The price to earnings (P/E) ratio for DexCom (DXCM) stock is 42.83 as of October 12, 2024.

Does DexCom stock pay dividends?

No, DexCom (DXCM) stock does not pay dividends to its shareholders as of October 12, 2024.

When is the next DexCom dividend payment date?

DexCom (DXCM) stock does not pay dividends to its shareholders.

What is the beta indicator for DexCom?

DexCom (DXCM) has a beta rating of 1.16. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.